Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Time-to-treatment window and cross-sex potential of β2-adrenergic receptor-induced mitochondrial biogenesis-mediated recovery after spinal cord injury

Toxicology and Applied Pharmacology(2020)10.1016/j.taap.2020.115366Source: DataRank Database

Time-to-treatment window and cross-sex potential of β2-adrenergic receptor-induced mitochondrial biogenesis-mediated recovery after spinal cord injury is a research paper published in Toxicology and Applied Pharmacology (2020). On theSindex it has a DataRank of 0. It has been cited 21 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access21 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.46)OA: bronzeTopics (58)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Epiphani C. Simmons ORCID,Josh D. Crossman,Rick G. Schnellmann ORCID,Natalie E. Scholpa ORCID

Live enrichment

PubMed:33316273 PMC:PMC12614272 OpenAlex:https://openalex.org/W3111638193

Department of Defense Spinal Cord Injury Research Program

Grant: SC180122

Biomedical Laboratory Research and Development

Grant: BX: 005218

National Institutes of Health

Grant: S10 OD011981

BLRD VA

Grant: I01 BX004868

BLRD VA

Grant: IK2 BX005218

Department of Veterans Affairs

FWCI

1.46

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2024

2025

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttps://www.sciencedirect.com/science/article/am/pii/S0041008X20304889?via%3Dihub

publisherhttps://www.sciencedirect.com/science/article/am/pii/S0041008X20304889?via%3Dihub

publisherhttps://api.elsevier.com/content/article/PII:S0041008X20304889?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0041008X20304889?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.taap.2020.115366

Fields of Study

Spinal Cord Injury ResearchCardiac Arrest and ResuscitationMuscle activation and electromyography studiesAdrenergic beta-2 Receptor AgonistsAnimalsBody CompositionDisease Models, AnimalDose-Response Relationship, DrugDrug Administration ScheduleFemaleFormoterol FumarateMaleMice, Inbred C57BLMitochondria, MuscleMuscle, SkeletalOrganelle BiogenesisReceptors, Adrenergic, beta-2Recovery of FunctionSex FactorsSpinal CordSpinal Cord InjuriesTime FactorsTime-to-TreatmentMice

MeSH Terms

Formoterol FumarateAnimalsOrganelle BiogenesisBody CompositionDisease Models, AnimalDose-Response Relationship, DrugDrug Administration ScheduleFemaleMaleMice, Inbred C57BLMitochondria, MuscleSex FactorsSpinal CordSpinal Cord InjuriesTime FactorsReceptors, Adrenergic, beta-2Muscle, SkeletalRecovery of FunctionMiceAdrenergic beta-2 Receptor AgonistsTime-to-Treatment

Keywords

FormoterolSpinal cord injuryMitochondrial biogenesisMedicineEndocrinologyInternal medicineSpinal cordAnesthesiaLesionMitochondrionBiologySurgeryLocomotor Recovery

Sustainable Development Goals

SDG 0: Good health and well-being